Humacyte reported revenue of $0.41M and net income of -$36.80M for the quarter ended Jun 2026, up 34.9% year over year. This income statement covers 24 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 43.95M | 39.97M | 103.00M | 103.01M | 103.10M | 103.23M | 103.33M | 103.41M | 103.46M | 103.67M | 119.08M | 119.35M | 119.84M | 130.03M | 155.12M | 156.34M | 158.84M | 158.16M | 222.02M | 277.80M | ||||
| Revenue & cost | ||||||||||||||||||||||||
| Revenue | 0.24M | 0.52M | 0.30M | 0.75M | 0.47M | 0.49M | 0.41M | |||||||||||||||||
| Gross Profit | 0.37M | 0.09M | 0.49M | -8.62M | -1.54M | -0.82M | ||||||||||||||||||
| Operating items | ||||||||||||||||||||||||
| Research & DevelopmentR&D | 15.39M | 16.25M | 16.31M | 14.65M | 17.34M | 14.96M | 17.28M | 20.54M | 18.55M | 20.18M | 21.26M | 23.75M | 22.93M | 20.66M | 15.42M | 22.01M | 17.27M | 14.61M | 19.46M | 18.14M | ||||
| Selling, General & AdministrativeSG&A | 5.40M | 5.55M | 5.68M | 5.18M | 6.19M | 5.83M | 5.23M | 6.19M | 6.07M | 6.00M | 5.31M | 5.75M | 7.31M | 7.43M | 8.14M | 7.81M | 7.61M | 7.62M | 7.93M | 8.03M | ||||
| Other Operating ExpensesOther Opex | 0.15M | 0.21M | 0.26M | 9.08M | 2.04M | 1.23M | ||||||||||||||||||
| Operating ExpensesOpex | 20.78M | 21.80M | 22.00M | 19.83M | 23.52M | 20.79M | 22.51M | 26.73M | 24.62M | 26.18M | 26.58M | 29.50M | 30.23M | 28.09M | 23.70M | 30.03M | 25.14M | 31.30M | 29.43M | 27.40M | ||||
| Operating IncomeOp. Inc | -20.54M | -21.61M | -21.80M | -18.53M | -23.49M | -20.80M | -22.51M | -26.73M | -24.62M | -26.15M | -26.60M | -29.50M | -30.23M | -28.09M | -23.20M | -29.73M | -24.39M | -30.84M | -28.93M | -27.00M | ||||
| EBIT | -20.54M | -21.61M | -21.80M | -18.53M | -23.49M | -20.80M | -22.51M | -26.73M | -24.62M | -26.15M | -26.60M | -29.50M | -30.23M | -28.09M | -23.20M | -29.73M | -24.39M | -30.84M | -28.93M | -27.00M | ||||
| Non-operating items | ||||||||||||||||||||||||
| Non Operating Interest Expenses | 1.20M | 1.40M | 1.43M | 1.49M | 1.64M | 1.64M | 1.70M | 1.71M | 1.46M | 1.73M | 1.82M | 2.52M | 2.44M | 2.51M | 3.00M | 2.54M | 2.61M | 3.09M | 2.27M | 2.32M | ||||
| Non Operating Investment Income | ||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.00M | 0.01M | 0.03M | 0.30M | 0.88M | 1.41M | 1.48M | 1.48M | 1.37M | 1.14M | 1.03M | 1.31M | 0.91M | 0.85M | 0.66M | 0.83M | 0.59M | 0.50M | 0.33M | 0.39M | ||||
| Other Non Operating IncomeOther Non Op Inc. | 0.23M | -0.07M | 0.18M | -0.04M | -2.42M | -0.14M | 0.06M | -0.39M | 1.05M | 3.20M | 14.93M | -0.75M | 4.01M | 20.57M | 8.53M | -5.16M | ||||||||
| Non Operating IncomeNon Op. Inc. | -11.02M | 64.21M | 1.93M | 55.40M | -1.79M | 17.07M | -14.46M | 4.03M | -1.37M | 1.08M | -5.32M | -27.16M | -8.97M | 7.15M | 62.32M | -7.93M | 6.88M | 6.03M | 11.32M | -9.81M | ||||
| Net income details | ||||||||||||||||||||||||
| EBT | -31.56M | -22.99M | -23.20M | -19.72M | -24.25M | -21.02M | -22.74M | -26.96M | -24.72M | -26.73M | -27.39M | -30.70M | -31.76M | -29.75M | -25.54M | -31.44M | -26.41M | -33.43M | -30.88M | -28.93M | ||||
| Profit After TaxPAT | -31.56M | 42.59M | -19.83M | 36.87M | -25.28M | -3.72M | -36.97M | -22.71M | -26.00M | -25.11M | -31.90M | -56.66M | -39.20M | -20.94M | 39.14M | -37.66M | -17.51M | -24.80M | -17.62M | -36.80M | ||||
| Income from Continuing OperationsIncome (Continuing) | -31.56M | -22.99M | -23.20M | -19.72M | -24.25M | -21.02M | -22.74M | -26.96M | -24.72M | -26.73M | -27.39M | -30.70M | -31.76M | -29.75M | -25.54M | -31.44M | -26.41M | -33.43M | -30.88M | -28.93M | ||||
| Consolidated Net IncomeConsol Net Inc. | -31.56M | -22.99M | -23.20M | -19.72M | -24.25M | -21.02M | -22.74M | -26.96M | -24.72M | -26.73M | -27.39M | -30.70M | -31.76M | -29.75M | -25.54M | -31.44M | -26.41M | -33.43M | -30.88M | -28.93M | ||||
| Income towards Parent CompanyParent Net Inc | -31.56M | -22.99M | -23.20M | -19.72M | -24.25M | -21.02M | -22.74M | -26.96M | -24.72M | -26.73M | -27.39M | -30.70M | -31.76M | -29.75M | -25.54M | -31.44M | -26.41M | -33.43M | -30.88M | -28.93M | ||||
| Net Income towards Common StockholdersNet Income | -31.56M | -22.99M | -23.20M | -19.72M | -24.25M | -21.02M | -22.74M | -26.96M | -24.72M | -26.73M | -27.39M | -30.70M | -31.76M | -29.75M | -25.54M | -31.44M | -26.41M | -33.43M | -30.88M | -28.93M | ||||
| Additional items | ||||||||||||||||||||||||
| EPS (Basic) | -0.72 | -0.58 | -0.23 | -0.19 | -0.24 | -0.20 | -0.22 | -0.26 | -0.24 | -0.26 | -0.25 | -0.26 | -0.27 | -0.25 | -0.19 | -0.20 | -0.17 | -0.21 | -0.16 | -0.12 | ||||
| EPS (Diluted) | -0.72 | -0.58 | -0.23 | -0.19 | -0.24 | -0.20 | -0.22 | -0.26 | -0.24 | -0.26 | -0.25 | -0.26 | -0.27 | -0.25 | -0.19 | -0.20 | -0.17 | -0.21 | -0.16 | -0.12 | ||||
| Shares Outstanding | 43.95M | 39.97M | 103.00M | 103.01M | 103.03M | 103.05M | 103.26M | 103.36M | 103.44M | 103.42M | 108.25M | 119.17M | 119.41M | 118.48M | 131.50M | 155.44M | 158.31M | 158.16M | 197.85M | 234.18M | ||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 43.95M | 39.97M | 103.00M | 103.91M | 103.03M | 103.05M | 103.26M | 103.36M | 103.44M | 103.42M | 108.25M | 119.17M | 119.41M | 118.48M | 131.76M | 155.44M | 158.31M | 158.16M | 197.85M | 234.18M | ||||
| EBITDA | -20.54M | -21.61M | -21.80M | -18.53M | -23.49M | -20.80M | -22.51M | -26.73M | -24.62M | -26.15M | -26.60M | -29.50M | -30.23M | -28.09M | -23.20M | -29.73M | -24.39M | -30.84M | -28.93M | -27.00M | ||||
| Interest ExpensesInt Expense | 1.20M | 1.40M | 1.43M | 1.49M | 1.64M | 1.64M | 1.70M | 1.71M | 1.46M | 1.73M | 1.82M | 2.52M | 2.44M | 2.51M | 3.00M | 2.54M | 2.61M | 3.09M | 2.27M | 2.32M |